LXEO – lexeo therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Lexeo Therapeutics (LXEO) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Will Lexeo Therapeutics (NASDAQ:LXEO) Spend Its Cash Wisely? [Yahoo! Finance]
Lexeo Therapeutics GAAP EPS of -$0.27 beats by $0.04 [Seeking Alpha]
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference
Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Form 4 Lexeo Therapeutics, Inc. For: Apr 06 Filed by: Townsend Richard Nolan
Form 144 Lexeo Therapeutics, Inc. Filed by: Townsend Richard Nolan
Form S-8 Lexeo Therapeutics, Inc.
Form 10-K Lexeo Therapeutics, Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.